Login or Sign Up
15:59 Feb 26
Sanofi India Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Sanofi India Ltd. Financials
Sanofi India Ltd.
Industry Pharmaceuticals
15:59 Feb 26
Quality
45/100
Medium Financial Strength
Valuation
34/100
Mid Valuation
Technical
39/100
Technically Neutral
Strength
4
Weakness
9
Opportunity
0
Threats
1
48.02 %
ROE %
25.64 %
ROA %
141.85
EPS
374.17
BVPS
20.52 %
Net Profit Margin
| Dec 2023 | Dec 2024 | ||
|---|---|---|---|
| Net Sales | 2851.1 | 2013.2 | |
| Operating Expenses + | 2047.4 | 1522.4 | |
| Raw Material | 1493.4 | 919.1 | |
| Increase Decrease in Cost | -292.4 | 60.2 | |
| Other Manufacturing Expense | 0 | 0 | |
| Employee Cost | 370.6 | 240.2 | |
| Miscellaneous Expenses | 2333.8 | 1431.5 | |
| Operating Profit | 803.7 | 490.8 | |
| Other Income | 65.3 | 16.5 | |
| Depreciation | 39.6 | 36.7 | |
| Interest | 1.7 | 1.5 | |
| Profit before tax and exceptio.. | 827.7 | 469.1 | |
| Exceptional Items | 17.8 | -37.7 | |
| PBT | 845.5 | 431.4 | |
| Provision for Taxation | 242.6 | 117.7 | |
| Net Profit | 602.9 | 413.3 | |
| NET Profit after MI | 602.9 | 413.3 | |
| EPS | 261.78 | 179.46 | |
| Operating Profit Margin (%) | 28.19 | 24.38 | |
| Net Profit Margin (%) | 21.15 | 20.53 |
Sanofi India Ltd. Shareholding
Promoter
FII
Public
All Data in Percentage (%)
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|
| Promoter | 60.40 | 60.40 | 60.40 | 60.40 | 60.40 | 60.40 |
| FII | 5.60 | 5.60 | 5.60 | 5.60 | 5.60 | 5.80 |
| Public | 21.20 | 22.20 | 23.10 | 23.00 | 23.00 | 22.80 |
| Others | 12.80 | 11.80 | 10.90 | 11.00 | 11.00 | 11.00 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
Back
OTP sent to your mobile number. Please enter it below to verify.
Verify Email OTP
OTP sent to
Dear User, please
complete your profile!
Email ID Already Exists
Location Saved
Successfully
Email Id Verified
Successfully